Topic summary

Second pass at: Manufacturer assistance programmes and their eligibility rules

Access › Pricing cost per milligram data table compounding formulary

This is a generated summary. It shows the 5 most-liked posts from a topic of 18, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.

j.delacroixTL3Regular20 Jan 2025#1

Second pass at: Manufacturer assistance programmes and their eligibility rules — setting out what I have, and where I think it stops being reliable.

Documenting an access outcome, dated, because everything in this category expires.

As of February 2026, in my region, the position is as described below. I have linked the primary source rather than a summary of it, because the summaries are consistently a year behind.

If anyone can confirm or contradict this for their own region, please date your answer. An undated claim in this category is worse than no claim.

18 likes 18mo

h.nicolaidesTL3Regular6 Feb 2025#4

post #3 is right about the mechanism and I think understates the practical bit.

Compute cost per delivered dose at your dose if you want a number you can act on. That requires knowing your dose, vial volume, and whether you are using a vial or a pen.

29 likes 18mo

k.karlsenTL2 Moderator11 Feb 2025#5

p.onwuka, post #3: Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive. Go to post

Subscription services and subscriptions: some online clinics bundle compounds into subscription models with different pricing. Understanding the terms before committing matters.

14 likes in reply to #3 18mo

PSundbergTL2Member15 Mar 2025#14

sourced_claims, post #8: post #7 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this,… Go to post

Worth separating two things that post #10 runs together.

International pricing: the same compound costs very different amounts in different countries because healthcare systems and regulatory frameworks differ. Generally, US prices are higher than other developed nations.

26 likes in reply to #8 16mo

a.amankwahTL2 Moderator24 Mar 2025 · edited#17

k.karlsen, post #5: Subscription services and subscriptions: some online clinics bundle compounds into subscription models with different pricing. Understanding the terms before committing matters. Go to post

Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented failure of cheaper alternatives.

18 likes in reply to #5 16mo

Read the full topic (18 posts)

Suggested topics

Topic	Participants	Replies	Views	Activity
Pen wastage and its effect on real cost Access › Pricing cost per milligram compounding formulary data table Pen wastage and its effect on real cost Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that is what determines…	+29	33	19k	21mo
Coming back to: Cost per delivered dose, which is the number that matters Access › Pricing formulary data table compounding cost per milligram Under review On the subject in the title: Cost per delivered dose, which is the number that matters Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category…	+6	10	2.5k	19mo
Why the cheapest option is often not the cheapest Access › Pricing compounding formulary cost per milligram data table Solved Wiki Why the cheapest option is often not the cheapest I have a specific reason for asking rather than idle curiosity, and the context is below. Documenting an access outcome, dated, because everything in this…	+19	23	1.2k	12h
Pen wastage and its effect on real cost — the long version Access › Pricing formulary data table cost per milligram compounding Posting this under the heading it deserves: Pen wastage and its effect on real cost — the long version Everything below is what sits behind that. Documenting an access outcome, dated, because everything in…		2	34k	13mo
List price versus negotiated price versus what you pay Access › Pricing formulary data table compounding Under review On the subject in the title: List price versus negotiated price versus what you pay Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires.…	+99	115	11k	3mo

Related topics — sharing the tags cost per milligram, data table, compounding

Topic	Participants	Replies	Views	Activity
Revisiting: Aggregates and why a purity assay may miss them entirely Analytics › Impurities & related substances endotoxin testing HPLC counter-ion content water content Solved Posting this under the heading it deserves: Revisiting: Aggregates and why a purity assay may miss them entirely Everything below is what sits behind that. I would like to understand what this number means…	+48	53	918	8mo
Cross-border purchase rules within the EU Regional › European Union personal import formulary cost per milligram EMA On the subject in the title: Cross-border purchase rules within the EU Working notes rather than a conclusion. A coverage question with the paperwork detail included, since that is what determines the answer.…	+45	49	15k	8mo
[2026 update] Why 99.2% and 97.8% on the same lot can both be correct Analytics › HPLC & UHPLC UV & DAD detection system suitability peak integration gradient method Solved Why 99.2% and 97.8% on the same lot can both be correct — that is the question, and I have not found it answered plainly anywhere I have looked. I would like to understand what this number means before I…	+1	5	719	2d
[2026 update] Reporting a disappointing outcome, and why it belongs here Outcomes › Progress reports DXA long read data table Pinned Closed On the subject in the title: Reporting a disappointing outcome, and why it belongs here Working notes rather than a conclusion. Longitudinal report with the method stated, because a number without a method is…		2	11k	8mo
State-level differences that actually matter Regional › North America compounding telehealth insurance FDA Solved On the subject in the title: State-level differences that actually matter Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As of…	+6	10	56k	10mo